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For the last three decades myocardial perfusion imaging (MPI) with single 
photon emission computed tomography (SPECT) has been an excellent tool for guiding 
clinicians in the management of patients with known or suspected coronary artery 
disease (CAD). However, despite its documented high diagnostic accuracy1 myocardial 
perfusion SPECT may fail to detect the true extent of coronary atherosclerosis and thus 
underestimate the coronary risk in individual patients.2 In fact, large observational 
studies have shown that 43%3 of patients suffering a myocardial infarction and 31%4 of 
patients dying from a cardiac cause had a normal or only mildly abnormal prior 
perfusion scan. A possible explanation for these shortcomings is inherent in the nature 
of the technique. MPI evaluates the hemodynamic relevance of coronary stenoses and 
therefore can only detect obstructive coronary lesions. However, approximately half of 
patients with normal SPECT perfusion have subclinical CAD on coronary CT 
angiography (CTA).5 Histopathological correlation studies demonstrate that almost 70% 
of coronary occlusions (leading to myocardial infarction) result from thrombosis of 
lesions with a stenosis of less than 50% before infarction.6 This explains to some extent 
why - despite evidence of normal myocardial perfusion - patients with subclinical CAD 
are at higher risk of coronary events, and underlines the importance of assessing the 
full (i.e. subclinical) extent of CAD to guide therapeutic decisions.7  
The recent few years have witnessed tremendous technological advances in 
coronary multislice CTA paralleled by an increased use of this technology in clinical 
practice. Given its high spatial resolution, its noninvasiveness, its relative ease of use, 
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and its complementary nature to MPI, CTA has been used as an ideal partner modality 
for hybrid (or multimodality) imaging with nuclear techniques. Additionally, the 
increased availability of dedicated fusion software packages for three-dimensional 
coregistration of CTA and MPI have facilitated the use of hybrid imaging in clinical 
practice.8,9 The feasibility and clinical robustness of noninvasive hybrid imaging was 
first documented by Namdar and coworkers in a clinical study involving fusion of 13N-
ammonia positron emission tomography (PET) with 4-slice CTA in 25 patients with 
CAD.10 The hybrid PET/CTA images allowed to identify flow-limiting coronary lesions 
which required a revascularization procedure (as defined by invasive coronary 
angiography and PET) with a sensitivity, specificity, positive and negative predictive 
value of 90%, 98%, 82%, and 99%, respectively. These encouraging results were 
confirmed by a similar study with SPECT/CTA showing that the hybrid approach 
resulted in a significant improvement in specificity (from 63% to 95%) and positive 
predictive value (from 31% to 77%) compared to CTA alone for detecting flow-limiting 
coronary stenoses.11 Santana and colleagues showed significantly higher diagnostic 
performance for fused SPECT/CT imaging compared to SPECT alone (p<0.001) and to 
the side-by-side analysis of SPECT and CT (p=0.007) for the diagnosis of obstructive 
CAD on invasive coronary angiography. Interestingly, this improved diagnostic 
performance was mainly a result of a higher sensitivity in patients with multivessel 
disease.12 A recent study implementing motion-frozen SPECT data and CTA-guided 
SPECT contour and territory adjustments, found that the improved diagnostic value of 
hybrid imaging was mainly driven by higher diagnostic indeces in the left circumflex 
(LCX) and right coronary artery (RCA) territories.13 Traditionally, LCX and RCA are 
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subject to more variable patterns of coronary artery anatomy than the left anterior 
descending artery, which explains the particular value of hybrid imaging in these 
territories.  
The study presented in this issue of the Journal of Nuclear Cardiology by Sato 
and coworkers14 adds importantly to previously published studies and further 
underscores the complementary and incremental diagnostic value of SPECT and CTA. 
They report on the accuracy of combined imaging with 64-slice CTA and 201Thallium 
SPECT for detecting significant coronary stenoses on invasive coronary angiography in 
130 patients with suspected CAD and an intermediate pretest likelihood of disease. 
The analysis was performed on intention-to-diagnose, considering nonevaluable 
segments (14%) on CTA as positive. Compared to CTA alone, the combined 
SPECT/CTA analysis resulted in a significant increase in specificity (from 80% to 92%) 
and positive predictive value (from 69% to 85%) without any change in sensitivity and 
negative predictive value. This effect was preserved across all vascular territories and 
on patient-based analysis. These results indicate that – in line with findings from prior 
studies – CTA tends to overestimate coronary stenoses and the combination with 
SPECT allows disproving many false positive CTA findings. Specificity and positive 
predictive value are particularly suboptimal in the presence of motion artefacts or 
severe coronary calcifications. With their study, Sato and colleagues were also able to 
shed some light on the distribution of perfusion defects among nonevaluable coronary 
arteries. Interestingly, perfusion defects were rarely observed in vessels with motion 
artefacts, but were more frequent in severely calcified vessels (59%). Thus, a severely 
calcified nonevaluable segment should prompt further testing due to its relatively high 
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likelihood of obstructive disease whereas segments (particularly in the RCA) with 
motion artefacts are usually rather “benign”. 
Sato and colleagues, together with previously published data, provide a basis to 
guide our choice of diagnostic tests in patients with suspected CAD with an 
intermediate pretest probability of disease. In patients in the lower spectrum of 
intermediate probability, CTA may be the preferred test due to its high negative 
predictive value (97% in the study by Sato et al.) and lower prevalence of disease in 
this group of patients. In the presence of equivocal CTA findings or nonevaluable 
findings, MPI may disprove hemodynamically relevant CTA lesions or identify 
obstructive lesions requiring revascularisation. In patients with an intermediate-to-high 
pretest probability, the likelihood of coronary calcifications is higher and a lower positive 
predictive value of CTA can be anticipated, therefore MPI may be considered a better 
first-line test. CTA can be added in the presence of equivocal MPI findings suggestive 
of attenuation artefacts or microvascular disease.15 Of note, a combined SPECT/CTA 
approach is most useful in patients where the initial diagnostic test yields equivocal 
findings but should not be used routinely in all patients with suspected CAD. Thus, the 
most practical approach for clinical effectiveness and minimization of costs and 
radiation dose is sequential scanning (as practiced by Sato et al.) with the preferred 
imaging modality first and a complementary test added if required for clinical diagnosis 
and decision-making. 
   An important limitation commonly encountered in studies assessing the value of 
hybrid imaging is the lack of an appropriate gold standard, to which noninvasive hybrid 
imaging could be compared. As shown before, the findings from angiographic 
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techniques differ very often from perfusion findings by SPECT,16 therefore the simple 
angiographic stenosis (albeit accurately measured with quantitative coronary 
angiography by Sato et al.) is probably a poor standard to reflect the pathophysiologic 
and prognostic severity of CAD. This is why, to a certain extent, disagreement between 
SPECT/CTA and coronary angiography is unavoidable by nature of the tests used. For 
instance, if a 60% stenosis is correctly identified by CTA and coronary angiography, 
this will result in agreement between both techniques. However, if the lesion is not 
associated with a perfusion defect on SPECT, the combined SPECT/CTA analysis will 
classify this lesion as a “false negative” finding which will contribute to reduce the 
diagnostic accuracy of the combined technique. This apparent disagreement occurs 
because this particular 60% stenosis is not flow-limiting, a feature that is not assessed 
by quantitative coronary angiography.  
Finally, the added radiation dose from nuclear Imaging techniques and CT is an 
important issue limiting its clinical use. In the study by Sato et al. the total radiation 
dose from helical CTA (without tube current modulation) and 201Thallium SPECT 
exceeded 30 mSv. However, implementation of modern CT acquisition protocols such 
as prospective ECG-triggering17 and body mass adapted tube voltage and current 
modulation18 allows to reduce the radiation dose from CTA by 60-80%. Additionally, 
SPECT perfusion tracers with shorter physical half-lives (99mTc-tetrofosmin or 99mTc-
sestamibi) are associated with lower radiation doses than 201Thallium. A recent study 
with stress-only hybrid SPECT/CTA imaging reported a total radiation dose of 5.4 mSv 
for a combined study.19 
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The role of percutaneous coronary interventions (PCI) in patients with stable 
CAD remains a controversial issue, and it is a recognized fact, that stent implantations 
represent a key cost driver in modern cardiological practice. The current evidence from 
published trials emphasizes that, in patients with stable CAD and preserved left 
ventricular function, PCI fails to offer any prognostic benefit over optimal medical 
therapy, unless a significant amount (generally more than 10%) of the left ventricular 
myocardium is ischemic.20,21 In this case PCI might be more effective than medical 
therapy in reducing the ischemic burden and thereby improving the patients’ 
prognosis.22 However, in some patients, it may be challenging to identify the culprit 
lesion from the side-by-side evaluation of MPI and angiography (either CT or invasive). 
This may contribute to stent overuse to avoid “missing” any significant stenosis. The 
combination of MPI and CTA into a three-dimensional hybrid image allows to 
superimpose myocardial territories onto their subtending coronary arteries, thereby 
reliably identifying the culprit lesion requiring revascularization. In a previous report of 
38 patients with perfusion defects on SPECT, the number of lesions with equivocal 
hemodynamic relevance was significantly reduced with SPECT/CTA fusion compared 
to the side-by-side analysis.9 This comprehensive noninvasive approach might help to 
avoid PCI in nonobstructive lesions, thereby reducing stent overuse, cutting on 
healthcare costs and preventing excess coronary events.23 
 Cardiac multimodality imaging is a new and highly dynamic field of continuing 
research driven by the constant technological advances and innovation of non-invasive 
imaging and the increasing clinical interest. Its impact extends beyond its clinical utility 
onto the organization of diagnostic healthcare structures. Traditionally, the different 
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diagnostic tests in CAD diagnosis, i.e. CTA, MPI and invasive coronary angiography 
have been firmly in the hand of different medical specialities, i.e. radiology, nuclear 
medicine, and cardiology. However, it is foreseeable that the appropriate use of 
alternative and complementary tests will require their integration into joint clinical 
diagnostic services where experts in all methods collaborate (Figure).24 Colleagues 
with clinical and technical expertise together can exploit the potential of new techniques 
for studying both anatomy and pathophysiology. This process will be supported by a 
shift from specializing in a particular technique that is applied by cross-sectional 
imaging to multiple organs, to an organ or system-based approach where the 
diagnostic expert is more concerned with function, the integration of results into clinical 
decision-making, and the impact of diagnostic imaging on clinical outcomes.24 
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Figure 
 
 
Figure. Fusion beyond images. Possible organization of joint multi-disciplinary 
diagnostic services. Reprinted from Fraser AG et al.24 with permission of Oxford 
University Press.  
